Jeffrey L. Cummings

Professor of Neurology, Psychiatry and Biobehavioral Science, Director, Mary S. Easton Alzheimer’s Disease Research Center Director, Deane F. Johnson Center for Neurotherapeutics
Neurology, Psychiatry and Biobehavioral Science
David Geffen School of Medicine at UCLA, USA

Fields of interest

  • assessment of behavioral changes in dementia syndromes and for determining the behavioral effects of drugs in dementia clinical trials
  • functions and disorders of the human frontal lobes

Recent publications

Mendez M, Cummings JL:
A Clinical Approach, 3rd edition. Butterworths, Boston, 2003

Miller BL, Cummings JL (eds):
The Human Frontal Lobes: Functions and Disorders, second edition.
Guilford Press, New York, 2006

Cummings JL:
Neuropsychiatry of Alzheimer’s Disease and Related Dementias. Martin Dunitz, London,

Grill JD, Cummings JL:
Current therapeutic targets for the treatment of Alzheimer’s disease.
Expert Rev. Neurother., 2010, 10, 711-728

Cummings JL, Emre M, Aarsland D, Tekin S, Dronamraju N, Lane R:
Effects of rivastigmine in Alzheimer’s disease patients with and without hallucinations.
J. Alzheimers Dis., 2010, 20, 301-311

Apostolova LG, Thompson PM, Green AE, Hwang KS, Zoumalan C, Jack CR Jr, Harvey DJ, Petersen RC, Thal LJ, Aisen PS, Toga AW, Cummings JL, Decarli CS:
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI,
Hum. Brain Mapp., 2010, 31, 786-797

Gauthier S, Cummings J, Ballard C, Brodaty H, Grossberg G, Robert P, Lyketsos C.:
Management of behavioral problems in Alzheimer's disease.
Int. Psychogeriatr. 2010, 22, 346-372

Cummings JL:
Integrating symptomatic- and disease-modifying treatments.
CNS Spectr., 2008, 13, 28-30

Cummings JL:
Alzheimer's disease summit. Translating research advances into clinical practice.
CNS Spectr. 2008, 13, 4-5

Cummings JL:
Controversies in Alzheimer's disease drug development.
Int. Rev. Psychiatry, 2008, 20, 389-395